Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Thomas Kluiver

PhD student

Development of novel therapies for childhood liver cancer using liver tumor organoids

Phone 088 97 290 00

--

  • Multiomic analysis uncovers a continuous spectrum of differentiation and Wnt-MDK-driven immune evasion in hepatoblastoma

    • aug. 2025
    • Daniel, Münter, et al
    • Journal of Hepatology
  • Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids

    • dec. 2024
    • Thomas A., Kluiver, et al
    • Nature communications
  • Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids

    • nov. 2024
    • Thomas A, Kluiver, et al
    • Nature communications
  • Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

    • mrt. 2024
    • Annelisa M., Cornel, et al
    • Journal for ImmunoTherapy of Cancer
  • Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

    • mrt. 2024
    • Annelisa M, Cornel, et al
    • Journal for ImmunoTherapy of Cancer
View all publications